Large-scale testing (Phase 3)Study completedNCT06554184
What this trial is testing
HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
Who this might be right for
Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
Fujian Shengdi Pharmaceutical Co., Ltd. 706